Orbimed Advisors - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 114 filers reported holding DYNE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$2,799,000
-62.0%
220,400
-37.0%
0.05%
-29.7%
Q2 2021$7,364,000
+35.5%
350,0000.0%0.07%
+45.1%
Q1 2021$5,436,000
-26.0%
350,0000.0%0.05%
-20.3%
Q4 2020$7,350,000
+4.0%
350,0000.0%0.06%
-28.1%
Q3 2020$7,067,000350,0000.09%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders